Generic placeholder image

Current Bioactive Compounds

Author(s): Damilare Rotimi, Jennifer Chidubem Amanze, Adebola Busola Ojo, Matthew Iyobhebhe, Tobiloba Christiana Elebiyo and Oluwafemi Adeleke Ojo*

DOI: 10.2174/1573407218666211231121402

DownloadDownload PDF Flyer Cite As
Kolaviron, A Biflavonoid Compound: Its Pharmacological Activity and Therapeutic Efficacy

Article ID: e311221199738 Pages: 9

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

The use of herbal remedies for medicinal purposes is becoming more popular around the world. As a result, plants have become viable treatment options for a variety of diseases. Garcinia kola (bitter kola) is a perennially grown plant in the Guttiferae family that has been evaluated and reported to have numerous health-promoting properties. Kolaviron is a biflavanoid and major phytochemical found in Garcinia kola that includes Garcinia Biflavanoid-1 (GB-1), kolaflavanone, and Garcinia Biflavanoid-2 (GB-2). It is obtained as a fraction extracted from Garcinia kola. Kolaviron's pharmacological properties include anti-inflammatory, anti-spasmodic, ameliorative, anti-asthmatic, anti-cancer, anti-malarial, hepatoprotective, antioxidant, anti-atherogenic, neuroprotective, anti-diabetic, and anti-amnesic properties. Kolaviron is recommended for use in clinical settings because it has been shown to have a high therapeutic efficacy in clinical trials. The purpose of this review is to assess the therapeutic efficacy of kolaviron.

Keywords: Kolaviron, Garcinia kola, pharmacological activities, natural products, therapeutic efficacy, Guttiferae.

Graphical Abstract

[1]
Iwu, M.M. Handbook of African medicinal plants; Routledge Hand books: UK, 2014.
[http://dx.doi.org/10.1201/b16292]
[2]
Joshua, O. Benefits of traditional medicine in the modern world. 2020.
[3]
Akinyemi, K.A. Antibacterial screening of five Nigerian medicinal plants against S. typhi and S. paratyphi. J. Nigerian Infect. Cont. Associ., 2000, 3(1), 30-33.
[4]
Ezekwesili-Ofili, J.O.; Okaka, A.N.C. Herbal Medicines in African Traditional Medicine. In: Herbal Medicine; Builders, Philip F., Ed.; Intech Open, 2019; p. 10.
[5]
Icheku, V.; Onianwah, F.; Nwulia, A. A descriptive cross-sectional study on various uses and outcomes of Garcinia kola among people of Oshimili North in the Delta State of Nigeria. Ayu, 2018, 39(3), 132-138.
[http://dx.doi.org/10.4103/ayu.AYU_195_16] [PMID: 31000989]
[6]
Mugendi, D.; Mucheru, M.; Kungu, J.; Otor, S.; Micheni, A.; Mugwe, J. Soil fertility improvement strategies for increased food production in the central highlands of Kenya. African Crop Sci. Confer., 2001, 5, 897-904.
[7]
Ekene, E.N. Garcinia kola: A review of its ethnomedicinal, chemical and pharmacological properties. Int. J. Curr. Res. Rev., 2014, 6(11), 1.
[8]
Ajayi, T.O.; Moody, J.O.; Fukushi, Y.; Adeyemi, T.A.; Fakeye, T.O. Antimicrobial activity of Garcinia kola (Heckel) seed extracts and isolated constituents against caries-causing microorganisms. Afr. J. Biomed. Res., 2014, 17(3), 165-171.
[9]
Iwu, M.W.; Duncan, A.R.; Okunji, C.O. New Antimicrobials of Plant Origin; ASHS Press: Alexandria, VA, 1999, pp. 457-462.
[10]
Iwu, M.M.; Igboko, O.A.; Okunji, C.O.; Tempesta, M.S. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. J. Pharm. Pharmacol., 1990, 42(4), 290-292.
[http://dx.doi.org/10.1111/j.2042-7158.1990.tb05412.x] [PMID: 1974302]
[11]
Hussain, R.A.; Owegby, A.G.; Parimoo, P.; Waterman, P.G. Kolanone, a novel polyisoprenylated benzophenone with antimicrobial properties from the fruit of Garcinia kola. Planta Med., 1982, 44(2), 78-81.
[http://dx.doi.org/10.1055/s-2007-971406] [PMID: 7071196]
[12]
Iwu, M.; Igboko, O. Flavonoids of Garcinia kola seeds. J. Nat. Prod., 1982, 45(5), 650-651.
[http://dx.doi.org/10.1021/np50023a026]
[13]
Adaramoye, O.A.; Awogbindin, I.; Okusaga, J.O. Effect of kolaviron, a biflavonoid complex from Garcinia kola seeds, on ethanol-induced oxidative stress in liver of adult wistar rats. J. Med. Food, 2009, 12(3), 584-590.
[http://dx.doi.org/10.1089/jmf.2008.0138] [PMID: 19627207]
[14]
Farombi, E.O. African indigenous plants with chemotherapeutic potentials and biotechnological approach to the production of bioactive prophylactic agents. Afr. J. Biotechnol., 2003, 2(12), 662-671.
[http://dx.doi.org/10.5897/AJB2003.000-1122]
[15]
Farombi, E.O.; Nwaokeafor, I.A. Anti-oxidant mechanisms of kolaviron: Studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats. Clin. Exp. Pharmacol. Physiol., 2005, 32(8), 667-674.
[http://dx.doi.org/10.1111/j.0305-1870.2005.04248.x] [PMID: 16120195]
[16]
World Health Organization Assessment of therapeutic efficacy of antimalarial drugs: For uncomplicated falciparum malaria in areas with intense transmission. Division of Control of Tropical Diseases., 1996.
[17]
Geiger, H.; Quinn, C.J. 77re Flawnoids-Advances in Research; Harborne, J.B.; Mabry, T.J., Eds.; , 1982, p. 505.
[18]
Lin, Y.M.; Anderson, H.; Flavin, M.T.; Pai, Y.H.S.; Mata-Greenwood, E.; Pengsuparp, T.; Pezzuto, J.M.; Schinazi, R.F.; Hughes, S.H.; Chen, F.C. In vitro anti-HIV activity of biflavonoids isolated from Rhus succedanea and Garcinia multiflora. J. Nat. Prod., 1997, 60(9), 884-888.
[http://dx.doi.org/10.1021/np9700275] [PMID: 9322359]
[19]
Vlietinck, A.J.; De Bruyne, T.; Apers, S.; Pieters, L.A. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med., 1998, 64(2), 97-109.
[http://dx.doi.org/10.1055/s-2006-957384] [PMID: 9525100]
[20]
Bortey-Sam, N.; Ikenaka, Y.; Akoto, O.; Nakayama, S.M.M.; Asante, K.A.; Baidoo, E.; Obirikorang, C.; Mizukawa, H.; Ishizuka, M. Association between human exposure to heavy metals/metalloid and occurrences of respiratory diseases, lipid peroxidation and DNA damage in Kumasi, Ghana. Environ. Pollut., 2018, 235, 163-170.
[http://dx.doi.org/10.1016/j.envpol.2017.12.005] [PMID: 29288929]
[21]
Farombi, E.O.; Owoeye, O. Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid. Int. J. Environ. Res. Public Health, 2011, 8(6), 2533-2555.
[http://dx.doi.org/10.3390/ijerph8062533] [PMID: 21776245]
[22]
Ogunwa, T.H.; Fasimoye, R.Y.; Adeyelu, T.T. Studies on the interaction mechanisms of Garcinia kolaviron constituents with selected diabetes and neurodegenerative disease targets. J. Proteins Proteom., 2019, 10(3), 221-234.
[http://dx.doi.org/10.1007/s42485-019-00021-x]
[23]
Olaleye, S.B.; Farombi, E.O.; Adewoye, E.A.; Owoyele, B.V.; Onasanwo, S.A.; Elegbe, R.A. Analgesic and anti-inflammatory effects of kolaviron (a Garcinia kola seed extract). Afr. J. Biomed. Res., 2000, 3(3), 171-174.
[24]
Onasanwo, S.A.; Rotu, R.A. Antinociceptive and anti-inflammatory potentials of kolaviron: Mechanisms of action. J. Basic Clin. Physiol. Pharmacol., 2016, 27(4), 363-370.
[http://dx.doi.org/10.1515/jbcpp-2015-0075] [PMID: 26812784]
[25]
Ayepola, O.R.; Chegou, N.N.; Brooks, N.L.; Oguntibeju, O.O. Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses. BMC Complement. Altern. Med., 2013, 13(1), 363.
[http://dx.doi.org/10.1186/1472-6882-13-363] [PMID: 24359406]
[26]
Samuel, C.L.; Norma Yolanda, H.S.; Salvador Emilio, L.C.; Pedro, C.H.; Felipe De Jesús, A.V.; María Teresa, S. Survival and respiration of green abalone (Haliotis fulgens) facing very short-term marine environmental extremes. Mar. Freshwat. Behav. Physiol., 2019, 52(1), 1-15.
[http://dx.doi.org/10.1080/10236244.2019.1607734]
[27]
Farombi, E.O.; Adepoju, B.F.; Ola-Davies, O.E.; Emerole, G.O. Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural bioflavonoid of Garcinia kola seeds. Eur. J. Cancer Prev., 2005, 14(3), 207-214.
[http://dx.doi.org/10.1097/00008469-200506000-00003] [PMID: 15901988]
[28]
Adaramoye, O.A.; Popoola, B.O.; Farombi, E.O. Effects of Xylopia aethiopica (Annonaceae) fruit methanol extract on γ-radiation-induced oxidative stress in brain of adult male Wistar rats. Acta Biol. Hung., 2010, 61(3), 250-261.
[http://dx.doi.org/10.1556/ABiol.61.2010.3.2] [PMID: 20724272]
[29]
Adaramoye, O.A.; Adedara, I.A.; Farombi, E.O. Possible ameliorative effects of kolaviron against reproductive toxicity in sub-lethally whole body gamma-irradiated rats. Exp. Toxicol. Pathol., 2012, 64(4), 379-385.
[http://dx.doi.org/10.1016/j.etp.2010.10.002] [PMID: 21036568]
[30]
Farombi, E.O.; Abarikwu, S.O.; Adedara, I.A.; Oyeyemi, M.O. Curcumin and kolaviron ameliorate di-n-butylphthalate-induced testicular damage in rats. Basic Clin. Pharmacol. Toxicol., 2007, 100(1), 43-48.
[http://dx.doi.org/10.1111/j.1742-7843.2007.00005.x] [PMID: 17214610]
[31]
Farombi, E.O.; Ugwuezunmba, M.C.; Ezenwadu, T.T.; Oyeyemi, M.O.; Ekor, M. Tetracycline-induced reproductive toxicity in male rats: Effects of vitamin C and N-acetylcysteine. Exp. Toxicol. Pathol., 2008, 60(1), 77-85.
[http://dx.doi.org/10.1016/j.etp.2008.02.002] [PMID: 18406588]
[32]
Adaramoye, O.A.; Lawal, S.O. Effect of kolaviron, a biflavonoid complex from Garcinia kola seeds, on the antioxidant, hormonal and spermatogenic indices of diabetic male rats. Andrologia, 2014, 46(8), 878-886.
[http://dx.doi.org/10.1111/and.12160] [PMID: 24007369]
[33]
Omotoso, G.O.; Arietarhire, L.O.; Ukwubile, I.I.; Gbadamosi, I.T. The protective effect of kolaviron on molecular, cellular, and behavioral characterization of cerebellum in the rat model of demyelinating diseases. Basic Clin. Neurosci., 2020, 11(5), 609-618.
[http://dx.doi.org/10.32598/bcn.9.10.300] [PMID: 33643554]
[34]
Farombi, E.O.; Adedara, I.A.; Ajayi, B.O.; Ayepola, O.R.; Egbeme, E.E. Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin. Pharmacol. Toxicol., 2013, 113(1), 49-55.
[http://dx.doi.org/10.1111/bcpt.12050] [PMID: 23336970]
[35]
Farombi, E.O.; Akanni, O.O.; Emerole, G.O. Antioxidant and scavenging activities of flavonoid extract (kolaviron) of Garcinia kola seeds. Pharm. Biol., 2002, 40(2), 107-116.
[http://dx.doi.org/10.1076/phbi.40.2.107.5838]
[36]
Coulom, H.; Birman, S. Chronic exposure to rotenone models sporadic Parkinson’s disease in Drosophila melanogaster. J. Neurosci., 2004, 24(48), 10993-10998.
[http://dx.doi.org/10.1523/JNEUROSCI.2993-04.2004] [PMID: 15574749]
[37]
Cannon, J.R.; Greenamyre, J.T. Neurotoxic in vivo models of Parkinson’s disease recent advances. Prog. Brain Res., 2010, 184, 17-33.
[http://dx.doi.org/10.1016/S0079-6123(10)84002-6] [PMID: 20887868]
[38]
Khadrawy, Y.A.; Salem, A.M.; El-Shamy, K.A.; Ahmed, E.K.; Fadl, N.N.; Hosny, E.N. Neuroprotective and therapeutic effect of caffeine on the rat model of Parkinson’s disease induced by rotenone. J. Diet. Suppl., 2017, 14(5), 553-572.
[http://dx.doi.org/10.1080/19390211.2016.1275916] [PMID: 28301304]
[39]
Farombi, E.O.; Abolaji, A.O.; Farombi, T.H.; Oropo, A.S.; Owoje, O.A.; Awunah, M.T. Garcinia kola seed biflavonoid fraction (Kolaviron), increases longevity and attenuates rotenone-induced toxicity in Drosophila melanogaster. Pestic. Biochem. Physiol., 2018, 145, 39-45.
[http://dx.doi.org/10.1016/j.pestbp.2018.01.002] [PMID: 29482730]
[40]
Ishola, I.O.; Adamson, F.M.; Adeyemi, O.O. Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system. Metab. Brain Dis., 2017, 32(1), 235-245.
[http://dx.doi.org/10.1007/s11011-016-9902-2] [PMID: 27631100]
[41]
Farombi, E.O.; Awogbindin, I.O.; Farombi, T.H.; Oladele, J.O.; Izomoh, E.R.; Aladelokun, O.B.; Ezekiel, I.O.; Adebambo, O.I.; Abah, V.O. Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson’s disease. Neurotoxicology, 2019, 73, 132-141.
[http://dx.doi.org/10.1016/j.neuro.2019.03.005] [PMID: 30930291]
[42]
Adedara, I.A.; Awogbindin, I.O.; Owoeye, O.; Maduako, I.C.; Ajeleti, A.O.; Owumi, S.E.; Patlolla, A.K.; Farombi, E.O. Kolaviron via anti-inflammatory and redox regulatory mechanisms abates multi-walled carbon nanotubes-induced neurobehavioral deficits in rats. Psychopharmacology, 2020, 237(4), 1027-1040.
[http://dx.doi.org/10.1007/s00213-019-05432-8] [PMID: 31897575]
[43]
Igado, O.O.; Olopade, J.O.; Adesida, A.; Aina, O.O.; Farombi, E.O. Morphological and biochemical investigation into the possible neuroprotective effects of kolaviron (Garcinia kola bioflavonoid) on the brains of rats exposed to vanadium. Drug Chem. Toxicol., 2012, 35(4), 371-380.
[http://dx.doi.org/10.3109/01480545.2011.630005] [PMID: 22288905]
[44]
Salau, V.F.; Erukainure, O.L.; Ibeji, C.U.; Olasehinde, T.A.; Koorbanally, N.A.; Islam, M.S. Ferulic acid modulates dysfunctional metabolic pathways and purinergic activities, while stalling redox imbalance and cholinergic activities in oxidative brain injury. Neurotox. Res., 2020, 37(4), 944-955.
[http://dx.doi.org/10.1007/s12640-019-00099-7] [PMID: 31422569]
[45]
Greig, N.H.; Lahiri, D.K.; Sambamurti, K. Butyrylcholinesterase: An important new target in Alzheimer’s disease therapy. Int. Psychogeriatr., 2002, 14(Suppl. 1), 77-91.
[http://dx.doi.org/10.1017/S1041610203008676] [PMID: 12636181]
[46]
Melo, J.B.; Agostinho, P.; Oliveira, C.R. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci. Res., 2003, 45(1), 117-127.
[http://dx.doi.org/10.1016/S0168-0102(02)00201-8] [PMID: 12507730]
[47]
Adefegha, S.A.; Omojokun, O.S.; Oboh, G.; Fasakin, O.; Ogunsuyi, O. Modulatory effects of ferulic acid on cadmium-induced brain damage. J. Evid. Based Complementary Altern. Med., 2016, 21(4), NP56-NP61.
[http://dx.doi.org/10.1177/2156587215621726] [PMID: 26700313]
[48]
Szwajgier, D.; Borowiec, K. Phenolic acids from malt are efficient acetylcholinesterase and butyrylcholinesterase inhibitors. J. Inst. Brew., 2012, 118(1), 40-48.
[http://dx.doi.org/10.1002/jib.5]
[49]
Ijomone, O.M.; Obi, A.U. Kolaviron, isolated from Garcinia kola, inhibits acetylcholinesterase activities in the hippocampus and striatum of wistar rats. Ann. Neurosci., 2013, 20(2), 42-46.
[http://dx.doi.org/10.5214/ans.0972.7531.200203] [PMID: 25206011]
[50]
Tripathi, A.; Srivastava, U.C. Acetylcholinesterase: A versatile enzyme of nervous systems. Ann. Neurosci., 2010, 15(4), 106-111.
[http://dx.doi.org/10.5214/ans.0972.7531.2008.150403]
[51]
Freitas, R.M.; Sousa, F.C.; Viana, G.S.; Fonteles, M.M. Acetylcholinesterase activities in hippocampus, frontal cortex and striatum of Wistar rats after pilocarpine-induced status epilepticus. Neurosci. Lett., 2006, 399(1-2), 76-78.
[http://dx.doi.org/10.1016/j.neulet.2006.01.028] [PMID: 16481111]
[52]
Volpicelli-Daley, L.A.; Hrabovska, A.; Duysen, E.G.; Ferguson, S.M.; Blakely, R.D.; Lockridge, O.; Levey, A.I. Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. Mol. Pharmacol., 2003, 64(6), 1309-1316.
[http://dx.doi.org/10.1124/mol.64.6.1309] [PMID: 14645660]
[53]
Birks, J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst. Rev., 2006, 25(1), CD005593.
[PMID: 16437532]
[54]
Salau, V.F.; Erukainure, O.L.; Bharuth, V.; Ibeji, C.U.; Olasehinde, T.A.; Islam, M.S. Kolaviron stimulates glucose uptake with concomitant modulation of metabolic activities implicated in neurodegeneration in isolated rat brain, without perturbation of tissue ultrastructural morphology. Neurosci. Res., 2020, 169, 57-68.
[PMID: 32645363]
[55]
Hanhineva, K.; Törrönen, R.; Bondia-Pons, I.; Pekkinen, J.; Kolehmainen, M.; Mykkänen, H.; Poutanen, K. Impact of dietary polyphenols on carbohydrate metabolism. Int. J. Mol. Sci., 2010, 11(4), 1365-1402.
[http://dx.doi.org/10.3390/ijms11041365] [PMID: 20480025]
[56]
Aryaeian, N.; Sedehi, S.K.; Arablou, T. Polyphenols and their effects on diabetes management: A review. Med. J. Islam. Repub. Iran, 2017, 31, 134.
[http://dx.doi.org/10.14196/mjiri.31.134] [PMID: 29951434]
[57]
Adaramoye, O.A.; Adeyemi, E.O. Hypoglycaemic and hypolipidaemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia kola in streptozotocin-induced diabetes mellitus rats. J. Pharm. Pharmacol., 2006, 58(1), 121-128.
[http://dx.doi.org/10.1211/jpp.58.1.0015] [PMID: 16393472]
[58]
Damian, D.C.; Nweze, E.I.; Onyeke, C.C. The in vivo anti-plasmodium activity of Garcinia kola Heckel. J. Basic Pharmacol. Toxicol., 2017, 1(2), 27-31.
[59]
Oluwatosin, A.; Tolulope, A.; Ayokulehin, K.; Patricia, O.; Aderemi, K.; Catherine, F.; Olusegun, A. Antimalarial potential of kolaviron, a biflavonoid from Garcinia kola seeds, against Plasmodium berghei infection in Swiss albino mice. Asian Pac. J. Trop. Med., 2014, 7(2), 97-104.
[http://dx.doi.org/10.1016/S1995-7645(14)60003-1] [PMID: 24461521]
[60]
Agarwal, R. Severe asthma with fungal sensitization. Curr. Allergy Asthma Rep., 2011, 11(5), 403-413.
[http://dx.doi.org/10.1007/s11882-011-0217-4] [PMID: 21789577]
[61]
Ibulubo, M.T.; Eze, G.I.; Ozolua, R.I.; Baxter-Grillo, D.; Uwaya, D.O. Evaluation of the protective and ameliorative properties of Garcinia kola on histamine-induced bronchoconstriction in guinea pigs. Pharmacognosy Res., 2012, 4(4), 203-207.
[http://dx.doi.org/10.4103/0974-8490.102262] [PMID: 23225963]
[62]
Wogan, G.N.; Paglialunga, S.; Newberne, P.M. Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet. Toxicol., 1974, 12(5-6), 681-685.
[http://dx.doi.org/10.1016/0015-6264(74)90239-9] [PMID: 4375655]
[63]
Wang, H.; Dick, R.; Yin, H.; Licad-Coles, E.; Kroetz, D.L.; Szklarz, G.; Harlow, G.; Halpert, J.R.; Correia, M.A. Structure-function relationships of human liver cytochromes P450 3A: Aflatoxin B1 metabolism as a probe. Biochemistry, 1998, 37(36), 12536-12545.
[http://dx.doi.org/10.1021/bi980895g] [PMID: 9730826]
[64]
Nwankwo, J.O.; Tahnteng, J.G.; Emerole, G.O. Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cells by kolaviron biflavonoids and molecular mechanisms of action. Eur. J. Cancer Prev., 2000, 9(5), 351-361.
[http://dx.doi.org/10.1097/00008469-200010000-00010] [PMID: 11075889]
[65]
Alabi, Q.K.; Akomolafe, R.O.; Olukiran, O.S.; Nafiu, A.O.; Omole, J.G.; Adefisayo, A.M.; Oladele, A.A. Assessment of haematological and biochemical effects of kolaviron in male Wistar rats. J. Pharm. Res. Int., 2017, 16(3), 1-14.
[66]
Goldstein, J.L. Familial hypercholesterolemia. The Metabolic Basis of Inherited Disease; MC Graw Hill: New York, 2001.
[67]
Civeira, F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis, 2004, 173(1), 55-68.
[http://dx.doi.org/10.1016/j.atherosclerosis.2003.11.010] [PMID: 15177124]
[68]
Jacques, P.F.; Sulsky, S.I.; Perrone, G.E.; Jenner, J.; Schaefer, E.J. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann. Epidemiol., 1995, 5(1), 52-59.
[http://dx.doi.org/10.1016/1047-2797(94)00041-Q] [PMID: 7728285]
[69]
Adaramoye, O.A.; Nwaneri, V.O.; Anyanwu, K.C.; Farombi, E.O.; Emerole, G.O. Possible anti-atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 2005, 32(1-2), 40-46.
[http://dx.doi.org/10.1111/j.1440-1681.2005.04146.x] [PMID: 15730433]
[70]
Omole, J.G.; Ayoka, O.A.; Alabi, Q.K.; Adefisayo, M.A.; Asafa, M.A.; Olubunmi, B.O.; Fadeyi, B.A. Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats. J. Evid. Based Integr. Med., 2018, 23, 2156587218757649.
[http://dx.doi.org/10.1177/2156587218757649] [PMID: 29468886]
[71]
De Souza, C.A.; Santini, G.; Marino, G.; Nati, S.; Congiu, A.M.; Vigorito, A.C.; Damasio, E. Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin’s lymphomas: A phase II study. Braz. J. Med. Biol. Res., 2000, 33(7), 791-798.
[http://dx.doi.org/10.1590/S0100-879X2000000700009] [PMID: 10881054]
[72]
Kasdallah-Grissa, A.; Mornagui, B.; Aouani, E.; Hammami, M.; Gharbi, N.; Kamoun, A.; El-Fazaa, S. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol Alcohol., 2006, 41(3), 236-239.
[http://dx.doi.org/10.1093/alcalc/agh256] [PMID: 16517551]
[73]
Kasdallah-Grissa, A.; Mornagui, B.; Aouani, E.; Hammami, M.; El May, M.; Gharbi, N.; Kamoun, A.; El-Fazaâ, S. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci., 2007, 80(11), 1033-1039.
[http://dx.doi.org/10.1016/j.lfs.2006.11.044] [PMID: 17258234]
[74]
Adedara, I.A.; Farombi, E.O. Chemoprotection of ethylene glycol monoethyl ether-induced reproductive toxicity in male rats by kolaviron, isolated biflavonoid from Garcinia kola seed. Hum. Exp. Toxicol., 2012, 31(5), 506-517.
[http://dx.doi.org/10.1177/0960327111424301] [PMID: 22027498]
[75]
Adedara, I.A.; Vaithinathan, S.; Jubendradass, R.; Mathur, P.P.; Farombi, E.O. Kolaviron prevents carbendazim-induced steroidogenic dysfunction and apoptosis in testes of rats. Environ. Toxicol. Pharmacol., 2013, 35(3), 444-453.
[http://dx.doi.org/10.1016/j.etap.2013.01.010] [PMID: 23474402]
[76]
Akinmoladun, A.C.; Akinrinola, B.L.; Olaleye, M.T.; Farombi, E.O. Kolaviron, a Garcinia kola biflavonoid complex, protects against ischemia/reperfusion injury: Pertinent mechanistic insights from biochemical and physical evaluations in rat brain. Neurochem. Res., 2015, 40(4), 777-787.
[http://dx.doi.org/10.1007/s11064-015-1527-z] [PMID: 25638229]
[77]
Ulubay, M.; Yurt, K.K.; Kaplan, A.A.; Atilla, M.K. The use of diclofenac sodium in urological practice: A structural and neurochemical based review. J. Chem. Neuroanat., 2018, 87, 32-36.
[http://dx.doi.org/10.1016/j.jchemneu.2017.02.005] [PMID: 28179185]
[78]
Brogden, R.N.; Heel, R.C.; Pakes, G.E.; Speight, T.M.; Avery, G.S. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs, 1980, 20(1), 24-48.
[http://dx.doi.org/10.2165/00003495-198020010-00002] [PMID: 6772422]
[79]
Altman, R.; Bosch, B.; Brune, K.; Patrignani, P.; Young, C. Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology. Drugs, 2015, 75(8), 859-877.
[http://dx.doi.org/10.1007/s40265-015-0392-z] [PMID: 25963327]
[80]
Hamza, A.A. Curcuma longa, Glycyrrhiza glabra and Moringa oleifera ameliorate diclofenac-induced hepatoxicity in rats. Am. J. Pharmacol. Toxicol., 2007, 2(2), 80-88.
[http://dx.doi.org/10.3844/ajptsp.2007.80.88]
[81]
Alabi, Q.K.; Akomolafe, R.O.; Adefisayo, M.A.; Olukiran, O.S.; Nafiu, A.O.; Fasanya, M.K.; Oladele, A.A. Kolaviron attenuates diclofenac-induced nephrotoxicity in male Wistar rats. Appl. Physiol. Nutr. Metab., 2018, 43(9), 956-968.
[http://dx.doi.org/10.1139/apnm-2017-0788] [PMID: 29847737]
[82]
Farombi, E.O.; Shrotriya, S.; Surh, Y.J. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1. Life Sci., 2009, 84(5-6), 149-155.
[http://dx.doi.org/10.1016/j.lfs.2008.11.012] [PMID: 19081081]
[83]
Nanji, A.A.; Jokelainen, K.; Tipoe, G.L.; Rahemtulla, A.; Thomas, P.; Dannenberg, A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-κ B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 284(2), G321-G327.
[http://dx.doi.org/10.1152/ajpgi.00230.2002] [PMID: 12388178]
[84]
Kusakabe, T.; Nakajima, K.; Nakazato, K.; Suzuki, K.; Takada, H.; Satoh, T.; Oikawa, M.; Arakawa, K.; Nagamine, T. Changes of heavy metal, metallothionein and heat shock proteins in Sertoli cells induced by cadmium exposure. Toxicol. In Vitro, 2008, 22(6), 1469-1475.
[http://dx.doi.org/10.1016/j.tiv.2008.04.021] [PMID: 18556172]
[85]
Li, J.L.; Gao, R.; Li, S.; Wang, J.T.; Tang, Z.X.; Xu, S.W. Testicular toxicity induced by dietary cadmium in cocks and ameliorative effect by selenium. Biometals, 2010, 23(4), 695-705.
[http://dx.doi.org/10.1007/s10534-010-9334-0] [PMID: 20372978]
[86]
Akinloye, O.; Arowojolu, A.O.; Shittu, O.B.; Anetor, J.I. Cadmium toxicity: A possible cause of male infertility in Nigeria. Reprod. Biol., 2006, 6(1), 17-30.
[PMID: 16604149]
[87]
Maduabuchi, J.M.; Nzegwu, C.N.; Adigba, E.O.; Aloke, R.U.; Ezomike, C.N.; Okocha, C.E.; Obi, E.; Orisakwe, O.E. Lead and cadmium exposures from canned and non-canned beverages in Nigeria: A public health concern. Sci. Total Environ., 2006, 366(2-3), 621-626.
[http://dx.doi.org/10.1016/j.scitotenv.2005.12.015] [PMID: 16442590]
[88]
Farombi, E.O.; Adedara, I.A.; Akinrinde, S.A.; Ojo, O.O.; Eboh, A.S. Protective effects of kolaviron and quercetin on cadmium-induced testicular damage and endocrine pathology in rats. Andrologia, 2012, 44(4), 273-284.
[http://dx.doi.org/10.1111/j.1439-0272.2012.01279.x] [PMID: 22356231]
[89]
Adeloye, D. An estimate of the incidence and prevalence of stroke in Africa: A systematic review and meta-analysis. PLoS One, 2014, 9(6), e100724.
[http://dx.doi.org/10.1371/journal.pone.0100724] [PMID: 24967899]
[90]
Feigin, V.L.; Norrving, B.; Mensah, G.A. Global Burden of Stroke. Circ. Res., 2017, 120(3), 439-448.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.308413] [PMID: 28154096]
[91]
Mestre, H.; Cohen-Minian, Y.; Zajarias-Fainsod, D.; Ibarra, A. Pharmacological treatment of acute ischemic stroke. Neurodegenerative diseases; IntechOpen, 2013.
[http://dx.doi.org/10.5772/53774]
[92]
Radaelli, A.; Mancia, G.; Ferrarese, C.; Beretta, S. Eds.; New Concepts in Stroke Diagnosis and Therapy; Bentham Science Publishers, 2017.
[93]
Ojo, O.B.; Amoo, Z.A.; Saliu, I.O.; Olaleye, M.T.; Farombi, E.O.; Akinmoladun, A.C. Neurotherapeutic potential of kolaviron on neurotransmitter dysregulation, excitotoxicity, mitochondrial electron transport chain dysfunction and redox imbalance in 2-VO brain ischemia/reperfusion injury. Biomed. Pharmacother., 2019, 111, 859-872.
[http://dx.doi.org/10.1016/j.biopha.2018.12.144] [PMID: 30841465]